Urinary excretion of TNF receptors.
作者信息
Gardiner K R, Armstrong A M, Halliday M I
出版信息
Gut. 1996 Jan;38(1):153-4. doi: 10.1136/gut.38.1.153-b.
Abstract
摘要
相似文献
1
Urinary excretion of TNF receptors.肿瘤坏死因子受体的尿排泄
Gut. 1996 Jan;38(1):153-4. doi: 10.1136/gut.38.1.153-b.
2
Redeeming an old foe: protective as well as pathophysiological roles for tumor necrosis factor in inflammatory bowel disease.挽救宿敌：肿瘤坏死因子在炎症性肠病中的保护作用及其病理生理学作用。
Am J Physiol Gastrointest Liver Physiol. 2015 Feb 1;308(3):G161-70. doi: 10.1152/ajpgi.00142.2014. Epub 2014 Dec 4.
3
Activation of muscarinic receptors prevents TNF-α-mediated intestinal epithelial barrier disruption through p38 MAPK.毒蕈碱受体的激活通过p38丝裂原活化蛋白激酶防止肿瘤坏死因子-α介导的肠上皮屏障破坏。
Cell Signal. 2017 Jul;35:188-196. doi: 10.1016/j.cellsig.2017.04.007. Epub 2017 Apr 12.
4
Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes.尿肿瘤坏死因子在糖尿病期间促成钠潴留和肾肥大。
Am J Physiol Renal Physiol. 2003 Jan;284(1):F113-21. doi: 10.1152/ajprenal.00026.2002. Epub 2002 Aug 13.
5
[Serum concentration and urinary excretion of soluble receptors for tumor necrosis factor in patients with primary glomerulonephritis].[原发性肾小球肾炎患者血清肿瘤坏死因子可溶性受体浓度及尿排泄情况]
Pol Merkur Lekarski. 2003 Oct;15(88):383-6; discussion 386-7.
6
[Soluble TNF-alpha receptors].[可溶性肿瘤坏死因子-α受体]
Postepy Hig Med Dosw. 1997;51(5):567-75.
7
[Glomerular expression of tumor necrosis factor alpha (TNF-alpha) and of its receptors].
C R Seances Soc Biol Fil. 1993;187(4):434-9.
8
9
Tumor necrosis factor-alpha (TNF-alpha)-induced and interleukin-1 beta (IL-1 beta)-induced shedding of TNF receptors from gingival fibroblasts.肿瘤坏死因子-α（TNF-α）诱导和白细胞介素-1β（IL-1β）诱导牙龈成纤维细胞表面肿瘤坏死因子受体的脱落
J Interferon Cytokine Res. 2000 Dec;20(12):1077-82. doi: 10.1089/107999000750053744.
10
Tumor necrosis factor (TNF)-induced cutaneous necrosis is mediated by TNF receptor 1.肿瘤坏死因子（TNF）诱导的皮肤坏死由肿瘤坏死因子受体1介导。
J Inflamm. 1995;47(4):180-9.
本文引用的文献
1
Endotoxin and the release of tumor necrosis factor receptors.内毒素与肿瘤坏死因子受体的释放
Prog Clin Biol Res. 1994;388:383-97.
2
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).用抗肿瘤坏死因子嵌合单克隆抗体（cA2）治疗克罗恩病。
Gastroenterology. 1995 Jul;109(1):129-35. doi: 10.1016/0016-5085(95)90277-5.
3
Significance of systemic endotoxaemia in inflammatory bowel disease.全身内毒素血症在炎症性肠病中的意义。
Gut. 1995 Jun;36(6):897-901. doi: 10.1136/gut.36.6.897.
Zotero 插件